The Wall Street Journal (online registration required): A Food and Drug Administration panel could soon help determine the fate of billions of dollars in household-name pain drugs like Advil and Aleve over the question of which ones pose a greater cardiac risk.
An advisory committee of medical experts is expected to spend two days this week reaching a recommendation on whether the drug naproxen, sold as Aleve by Bayer AG, may carry little to no heart danger, giving it a possible boost over...
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now